Abstract
Post-hoc analysis of the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) study suggests that, in concordance with European guidelines, using bacteriologic criterion of ≥ 10,000 CFU/ml of a single organism does not decrease diagnostic specificity of a UTI in children aged 2 months to 6 years in a properly collected urine if symptoms/fever and pyuria are present.
Keywords: vesicoureteral reflux, suprapubic aspiration, urinary catheterization, pyuria, guideline
The RIVUR (Randomized Intervention for Children with Vesicoureteral Reflux [VUR])1 study showed that antibiotic prophylaxis with trimethoprim/sulfamethoxazole decreased the number of recurrent urinary tract infections (UTIs) in children 2 months to 6 years of age with VUR. In order to ensure rigorous diagnosis of a recurrent UTI, the study protocol required 3 criteria: fever and/or symptoms, pyuria, and growth of a single organism ≥100,000 colony forming units/ml (CFU/ml) for clean catch or ≥50,000 CFU/mL for a catheterized specimen. Since 2007 when the RIVUR trial was designed2, uncertainty has arisen as to the threshold for organism growth to appropriately diagnose a UTI in children3–4. Swerkersson recently showed that 12% of 430 children less than 12 months of age with a carefully diagnosed first UTI had colony counts of 10,000 to 50,000 CFU/ml.4 Current European and Canadian guidelines in infants and young children suggest that any growth on suprapubic aspiration (SPA) is abnormal5–7. European guidelines state that growth of 10,000 CFU/mL or even 1,000 CFU/ml are sufficient to diagnose a UTI from a catheterized urine5–7, while US and Canadian guidelines use 50,000 CFU/mL as the cut-off5–7,10.
Since the work of Kass et al in adult women in the 1950’s,8 100,000 CFU/mL of a single organism has been the diagnostic criterion for diagnosing a UTI in older children and adults. However, based in part on the work by Hoberman et al in children9, the recently reaffirmed American Academy of Pediatrics 2011 UTI guideline recommends that ≥50,000 CFU/mL of a single organism and pyuria be present in urine collected by SPA or catheterization in children 2–24 months of age in order to diagnosis a UTI10. We have reanalyzed RIVUR data in order to determine whether use of a lower criterion for bacterial growth, consistent with most international guidelines, would significantly change the number of children diagnosed with a recurrent UTI in this cohort. We hypothesize that lowering the bacteriologic threshold to ≥10,000 CFU/ml in order to diagnosis a UTI in a child with symptoms and pyuria would result in few if any false positives and thus have minimal impact on specificity and a minimal impact on sensitivity.
Methods
Application of the stringent RIVUR primary outcome definition was standardized by an independent UTI classification committee2. Specifically, a recurrent UTI required a cultureproven infection with a single organism ≥ 50 000 CFU/mL (catheterized or SPA urine) or ≥ 100 000 CFU/mL (cleanvoided); pyuria on microscopic urinalysis (≥ 5 wbc/mm in an uncentrifuged specimen or ≥ 10 wbc/hpf in a centrifuged specimen), or trace or greater leukocyte esterase on dipstick; and fever (38°C or greater) or symptoms (suprapubic, abdominal, or flank pain or tenderness; or urinary urgency, frequency, or hesitancy, or dysuria, or foul-smelling urine; or in infants aged 4 months or younger, failure to thrive, dehydration, or hypothermia) occurring within 24 hours of the urine collection. For the current analysis, data were first reanalyzed using the original RIVUR definition of a UTI but decreasing the colony count requirement to ≥ 50,000 CFU/mL for clean-voided specimens. Data were then reanalyzed using a colony count threshold of ≥10,000 colonies/CFU/ml for clean-voided, catheterized or SPA urines. Criteria for fever/symptoms and pyuria were unchanged.
Results
In the RIVUR trial 111 children of the enrolled 607 children had 171 recurrent UTIs that met the original protocol-specified criteria.1,2 (Table; available at www.jpeds.com) No additional children would have been diagnosed with a recurrent UTI if the culture criteria for a clean caught urine was dropped from >100,000 CFU/ml to ≥50,000 CFU/ml. One 8-month-old and 1 child older than 24 months, both of whom were receiving antibiotic prophylaxis, would have diagnosed with a recurrent UTI if the cut-off was decreased to ≥10,000 CFU/ml. Thus, lowering the colony count threshold to ≥10,000 colonies had little impact on the specificity of a recurrent UTI in the RIVUR study if both fever/symptoms and pyuria are present.
Table.
version 16 06 13
| Age | ||||
|---|---|---|---|---|
| Children | <= 6 months (N=147) | 6 to <= 24 months (N=258) | > 24 months (N=202) | Overall (N=607) |
| Children with RIVUR UTI (%with UTI within age group) | 21 (14%) | 44 (17%) | 46 (23%) | 111 |
| RIVUR UTI | 33 | 61 | 77 | 171 |
| C50+P+S | 33 | 61 | 77 | 171 |
| C10+P+S | 33 | 62 | 78 | 173 |
| RC+S (no P) | 40 | 73 | 88 | 201 |
| C50+S (no P) | 40 | 72 | 89 | 201 |
| C10+S (no P) | 40 | 73 | 90 | 203 |
C10 is culture 10k or greater
P is pyuria based on RIVUR definition
S is symptoms based on RIVUR definition of fever or symptoms within 24 hours
RC is RIVUR culture cutpoints (50k for cath, 100K for clean catch)
Discussion
Changing the colony count cut-off for diagnosis of a recurrent UTI in the RIVUR trial to ≥10,000 CFU/mL in children with symptoms and pyuria adds only two UTI diagnoses, has minimal impact on specificity and makes no difference in the conclusions of the RIVUR study. This lower threshold is consistent with the European guidelines and suggests that serious consideration be given to decreasing the bacteriologic criterion for a UTI in the AAP and Canadian guidelines to ≥10,000 colonies of a single organism in a properly collected urine in children between 2 months and 2 years of age if symptoms and pyuria are present. As most of the urines in children >2 years of age were clean caught the lower colony count recommendation appears to be valid for children between 2 and 6 years of age as well as for those less than 2 years. As 6 years was the cutoff for the RIVUR study, no recommendation can be made for older children.
Use of the lower criterion is especially pertinent in pediatrics, as an infant or young child with urinary frequency or urgency from a UTI may be unlikely to hold urine long enough to allow bacterial growth to reach 50 or 100,000 CFU/mL, leading to a risk of underdiagnosis, and possible subsequent morbidity. Kass in his classic studies demonstrated that 1% of his adult women in urine obtained randomly during the day had colony counts between 10,000 and 100,000 CFU/ml. 8 In these women UTI was confirmed by a ≥ 100,000 CFU/mL first morning urine, and the lower colony count obtained later in the day was attributed to hydration. Similarly, Pryles demonstrated the effect of hydration on colony count by subjecting several untreated children with UTI diagnosed by ≥107 CFU/mL on a first morning urine to serial catheterization during a 24-hour period and showed that the colony count during the day decreased by several orders of magnitude to as low as 103 to 104 CFU/mL.11 Koskimies reported that 19% of his patients with bacterial growth on SPA had less than 105 CFU/ml12. Lubell et al in a multicenter emergency department study of 1870 infants 29–60 days of age diagnosed with UTI based on symptoms and either pyuria or a positive urine gram stain found that 6% had colony counts of 10,000–49,000 CFU/mL, 3% reported as 10,000 to 100,000 CFU/ml, and 20% reported as 50,000 to 100,000 CFU/ml.13 Thus potentially 9% of these infants might not have been diagnosed with a UTI unless the colony count cut-off is decreased to 10,000 CFU/ml. Similarly Schroeder et al report that 5% of their infants less than 3 months of age with a bacteremic UTI had colony counts between 10,000 and 49,000 CFU/ml.14 Also, as is noted in these reports, because some laboratories report colony counts as 10,000 to 100,000 CFU/ml, the 50,000 CFU/ml threshold sometimes cannot be ascertained. Thus infected urine properly collected from a child with a UTI during an office or emergency room visit may sometimes grow only ≥10,000 CFU/ml. Because prompt therapy is reported to decrease the incidence of renal scarring, delay in treatment awaiting a repeat urine culture may be deleterious.15–16
The risks of underdiagnosis must be balanced against the risks of overdiagnosis, especially for the symptomatic child with bacteriuria without pyuria17. The likelihood of overdiagnosis in the RIVUR cohort was minimized because all the patients identified with a recurrent UTI had pyuria and symptoms or fever. In the RIVUR study, 29 children met the original criteria for a positive urine culture and fever/symptoms but did not demonstrate pyuria and thus were not diagnosed with a recurrent UTI. Lowering the culture criterion to ≥10,000 CFU/ml would add only one additional child for a total of 30. Half of these children grew organisms other than E. coli. Determining whether some of these children actually had a recurrent UTI is problematic. Shaikh18 found 13% of children with a UTI did not have pyuria, especially those infected with an organism other than E. coli. Similarly, Lubell found that the sensitivity of pyuria was 75.9% for infants with an enterocoocal UTI compared with 93.9% for those with an E. coli UTI.13 Perhaps when organisms other than E coli are found in a urine without pyuria, physicians should have a higher index of suspicion for a UTI as these organisms may generate less of an inflammatory response.
Limitations of this post-hoc analysis of the RIVUR study data are that the recurrent UTI’s were diagnosed by clinical and laboratory criteria and were not confirmed by contemporaneous radionucleide studies, the RIVUR trial was not designed to assess the bacteriologic criteria for diagnosing a UTI, and the relatively small number of patients studied. Also, since all the study subjects had vesicoureteral reflux and half were on prophylactic antibiotics, including the 2 additional cases (Table), data from this reanalysis may not be generalizable to the general pediatric population.
In summary, we suggest that decreasing the bacteriologic criterion for diagnosing a UTI in infants and children aged 2 months to 6 years with symptoms/fever and pyuria from ≥100,000 CFU/mL or ≥50,000 CFU/mL to ≥10,000 CFU/ml in a properly collected urine would not impact diagnostic specificity and would slightly increase sensitivity in concordance with the recently updated European guidelines.
Acknowledgments
The Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Study was conducted by the RIVUR investigators supported by grants U01 DK074059, U01 DK074053, U01 DK074082, U01 DK074064, U01 DK074062, U01 DK074063 from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The authors declare no conflicts of interest.
Abbreviations
- SPA
suprapubic aspiration
- RIVUR
Randomized Intervention for Children with Vesicoureteral Reflux
- UTI
urinary tract infection
- CFU
Colony forming units
Footnotes
Clinical trial registration: NCT00405704
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.RIVUR Trial Investigators. Hoberman A, Greenfield SP, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med. 2014 Jun 19;370:2367–2376. doi: 10.1056/NEJMoa1401811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Keren R, Carpenter MA, Hoberman A, et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics. 2008 Dec;122(Suppl 5):S240–250. doi: 10.1542/peds.2008-1285d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Tullus K. Low urinary bacterial counts: do they count? Pediatr Nephrol. 2016 Feb;31:171–174. doi: 10.1007/s00467-015-3227-y. [DOI] [PubMed] [Google Scholar]
- 4.Swerkersson S, Jodal U, Ahren C, Sixt R, Stokland E, Hansson S. Urinary tract infection in infants: the significance of low bacterial count. Pediatr Nephrol. 2016 Feb;31:239–245. doi: 10.1007/s00467-015-3199-y. [DOI] [PubMed] [Google Scholar]
- 5.Stein R, Dogan HS, Hoebeke P, Kocvara R, Nijman RJ, Radmajr C, et al. Urinary tract infections in children: EAU/ESPU guidelines. Eur Urol. 2015;67:546–58. doi: 10.1016/j.eururo.2014.11.007. [DOI] [PubMed] [Google Scholar]
- 6.Beetz R, Bachmann H, Gatermann S, Keller H, Kuwertz-Bröking E, Misselwitz J, et al. Urinary tract infections in infants and children—a consensus on diagnostic, therapy and prophylaxis. Urologe A. 2007;46:112–23. doi: 10.1007/s00120-006-1254-9. [DOI] [PubMed] [Google Scholar]
- 7.Ammenti A, Cataldi L, Chimenz R, et al. Febrile urinary tract infections in young children: recommendations for the diagnosis, treatment and follow-up. Acta Paediatr. 2012 May;101:451–457. doi: 10.1111/j.1651-2227.2011.02549.x. [DOI] [PubMed] [Google Scholar]
- 8.Kass EH. Asymptomatic infections of the urinary tract. Transactions of the Association of American Physicians. 1956;69:56–64. [PubMed] [Google Scholar]
- 9.Hoberman A, Wald ER, Reynolds EA, Penchansky L, Charron M. Pyuria and bacteriuria in urine specimens obtained by catheter from young children with fever. J Pediatr. 1994 Apr;124:513–519. doi: 10.1016/s0022-3476(05)83127-0. [DOI] [PubMed] [Google Scholar]
- 10.Subcommittee on Urinary Tract Infection. Reaffirmation of AAP Clincal Practice Guideline: Urinary Tract Infection: Clinical Practice Guideline for the Diagnosis and Management of the Initial UTI in Febrile Infants and Yooung Children 2 to 24 Months. Pediatrics. 2016 Dec;:138. doi: 10.1542/peds.2016-3026. pii: e20163026. [DOI] [PubMed] [Google Scholar]
- 11.Pryles CV, Lustik B. Laboratory diagnosis of urinary tract infection. Pediatric clinics of North America. 1971 Feb;18:233–244. doi: 10.1016/s0031-3955(16)32536-6. [DOI] [PubMed] [Google Scholar]
- 12.Koskimies O. Diagnostic accuracy of urinary tract infection and subsequent development of renal scars. J Pediatr. 1995;126:157–8. doi: 10.1016/s0022-3476(95)70532-5. [DOI] [PubMed] [Google Scholar]
- 13.Lubell TR, Schnadower D, Freedman SB, et al. Comparison of Febrile Infants With Enterococcal and Gram-negative Urinary Tract Infections. Pediatr Infect Dis J. 2016;35:943–948. doi: 10.1097/INF.0000000000001225. [DOI] [PubMed] [Google Scholar]
- 14.Schroeder AR, Chang PW, Shen MW, Biondi EA, Greenhow TL. Diagnostic Accuracy of the Urinalysis for Urinary Tract Inrfection in Infants < 3 months of age. Pediatrics. 2015;135:965–971. doi: 10.1542/peds.2015-0012. [DOI] [PubMed] [Google Scholar]
- 15.Coulthard MG, Lambert HJ, Vernon SJ, Hunter EW, Keir MJ, Matthews JN. Does Prompt Treatment of a Urinary Tract Infection in Preshcool Children Prevent Renal Scarring: Miced retrospective and Prospective Audits. Arch Dis Child. 2014;99:342–7. doi: 10.1136/archdischild-2013-304428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Karavanaki KA, Soldatou A, Koufadaki AM, Tsentidis C, Haliotis FA, Stefanidis CJ. Delayed Treatment of the first Febrile Uriinary Tract Infection in Early Childhood Increased the Risk of Renal Scarring. Acta Pediatr. 2017;106:149–154. doi: 10.1111/apa.13636. [DOI] [PubMed] [Google Scholar]
- 17.Roberts K. The Diagnosis of UTI: Liquid Gold and the Problem of Gold Standards. Pediatrics. 2015;135:1125–1127. doi: 10.1542/peds.2015-0884. [DOI] [PubMed] [Google Scholar]
- 18.Shaikh N, Shope TR, Hoberman A, Vigliotti A, Kurs-Lasky M, Martin JM. Association Between Uropathogen and Pyuria. Pediatrics. 2016:138. doi: 10.1542/peds.2016-0087. pii: e20160087. Epub 2016 Jun 21. [DOI] [PubMed] [Google Scholar]
